The role of chemical neurolysis in cancer pain

Dhanalakshmi Koyyalagunta; Allen W. Burton

doi:10.1007/s11916-010-0123-9

The role of chemical neurolysis in cancer pain

Dhanalakshmi Koyyalagunta, Allen W. Burton

Pain Medicine

Research output: Contribution to journal › Review article › peer-review

30 Scopus citations

Abstract

Pain continues to be a significant symptom burden in cancer patients, with prevalence in 53% of patients at all stages of cancer and as high as 58% to 69% in those with advanced cancer. Neurolytic blocks are a mainstay in the armamentarium of cancer pain management, more so in intractable pain from advanced cancer. There is no clear consensus on patient selection, technique, or timing of these blocks. Here we discuss the use of various neurolytic blocks for cancer pain and detail some of the recent literature and our experience.

Original language	English (US)
Pages (from-to)	261-267
Number of pages	7
Journal	Current Pain and Headache Reports
Volume	14
Issue number	4
DOIs	https://doi.org/10.1007/s11916-010-0123-9
State	Published - Aug 2010

Keywords

Cancer pain
Neurolysis

ASJC Scopus subject areas

Clinical Neurology
Anesthesiology and Pain Medicine

Access to Document

10.1007/s11916-010-0123-9

Cite this

@article{52d4f6f39c7e4e91961b9967c35e109e,

title = "The role of chemical neurolysis in cancer pain",

abstract = "Pain continues to be a significant symptom burden in cancer patients, with prevalence in 53% of patients at all stages of cancer and as high as 58% to 69% in those with advanced cancer. Neurolytic blocks are a mainstay in the armamentarium of cancer pain management, more so in intractable pain from advanced cancer. There is no clear consensus on patient selection, technique, or timing of these blocks. Here we discuss the use of various neurolytic blocks for cancer pain and detail some of the recent literature and our experience.",

keywords = "Cancer pain, Neurolysis",

author = "Dhanalakshmi Koyyalagunta and Burton, {Allen W.}",

note = "Funding Information: Disclosures Dr. Allen Burton received research funding from Med-tronic, Inc, has served as a consultant for Infusion Systems and Stryker, and served as a speaker for Elan. Dr. Dhanalakshmi Koyyalagunta has received research funding from Medtronic, Inc.",

year = "2010",

month = aug,

doi = "10.1007/s11916-010-0123-9",

language = "English (US)",

volume = "14",

pages = "261--267",

journal = "Current Pain and Headache Reports",

issn = "1531-3433",

publisher = "Current Science, Inc.",

number = "4",

}

TY - JOUR

T1 - The role of chemical neurolysis in cancer pain

AU - Koyyalagunta, Dhanalakshmi

AU - Burton, Allen W.

N1 - Funding Information: Disclosures Dr. Allen Burton received research funding from Med-tronic, Inc, has served as a consultant for Infusion Systems and Stryker, and served as a speaker for Elan. Dr. Dhanalakshmi Koyyalagunta has received research funding from Medtronic, Inc.

PY - 2010/8

Y1 - 2010/8

N2 - Pain continues to be a significant symptom burden in cancer patients, with prevalence in 53% of patients at all stages of cancer and as high as 58% to 69% in those with advanced cancer. Neurolytic blocks are a mainstay in the armamentarium of cancer pain management, more so in intractable pain from advanced cancer. There is no clear consensus on patient selection, technique, or timing of these blocks. Here we discuss the use of various neurolytic blocks for cancer pain and detail some of the recent literature and our experience.

AB - Pain continues to be a significant symptom burden in cancer patients, with prevalence in 53% of patients at all stages of cancer and as high as 58% to 69% in those with advanced cancer. Neurolytic blocks are a mainstay in the armamentarium of cancer pain management, more so in intractable pain from advanced cancer. There is no clear consensus on patient selection, technique, or timing of these blocks. Here we discuss the use of various neurolytic blocks for cancer pain and detail some of the recent literature and our experience.

KW - Cancer pain

KW - Neurolysis

UR - http://www.scopus.com/inward/record.url?scp=77956392697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956392697&partnerID=8YFLogxK

U2 - 10.1007/s11916-010-0123-9

DO - 10.1007/s11916-010-0123-9

M3 - Review article

C2 - 20524161

AN - SCOPUS:77956392697

SN - 1531-3433

VL - 14

SP - 261

EP - 267

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

IS - 4

ER -

The role of chemical neurolysis in cancer pain

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this